Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma

The use of sublobar resections as definitive management in stage I non-small cell lung carcinoma is a controversial topic in the medical community. We intend to report the latest developments and trends in relative indications for each of the above-mentioned surgical approaches for the treatment of...

Full description

Bibliographic Details
Main Authors: Konstantinos Reveliotis, George Kalavrouziotis, Konstantinos Skevis, Andriani Charpidou, Rodoula Trigidou, Kostas Syrigos
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-09-01
Series:Oncology Reviews
Subjects:
Online Access:http://www.oncologyreviews.org/index.php/or/article/view/234
_version_ 1797963066727464960
author Konstantinos Reveliotis
George Kalavrouziotis
Konstantinos Skevis
Andriani Charpidou
Rodoula Trigidou
Kostas Syrigos
author_facet Konstantinos Reveliotis
George Kalavrouziotis
Konstantinos Skevis
Andriani Charpidou
Rodoula Trigidou
Kostas Syrigos
author_sort Konstantinos Reveliotis
collection DOAJ
description The use of sublobar resections as definitive management in stage I non-small cell lung carcinoma is a controversial topic in the medical community. We intend to report the latest developments and trends in relative indications for each of the above-mentioned surgical approaches for the treatment of stage I non-small cell lung carcinoma as well as the results of studies regarding local recurrence, disease-free survival and five-year survival rates. We reviewed 45 prospective and retrospective studies conducted over the last 25 years listed in the Pubmed and Scopus electronic databases. Trials were identified through bibliographies and a manual search in journals. Authors, citations, objectives and results were extracted. No meta-analysis was performed. Validation of results was discussed. Segmentectomies are superior to wedge resections in terms of local recurrences and cancer-related mortality rates. Sublobar resections are superior to lobectomy in preserving the pulmonary parenchyma. High-risk patients should undergo segmentectomy, whereas lobectomies are superior to segmentectomies only for tumors >2 cm (T2bN0M0) in terms of disease-free and overall 5-year survival. In most studies no significant differences were found in tumors <2 cm. Disease-free surgical margins are crucial to prevent local recurrences. Systematic lymphadenectomy is mandatory regardless of the type of resection used. In sublobar resections with less thorough nodal dissections, adjuvant radiotherapy can be used. This approach is preferable in case of prior resection. In pure bronchoalveolar carcinoma, segmentectomy is recommended. Sublobar resections are associated with a shorter hospital stay. The selection of the type of resection in T1aN0M0 tumors should depend on characteristic of the patient and the tumor. Patient age, cardiopulmonary reserve and tumor size are the most important factors to be considered. However further prospective randomized trials are needed to investigate the efficacy of minimal resections in early lung cancer patients.
first_indexed 2024-04-11T01:22:31Z
format Article
id doaj.art-362c1bb02afa4d57a2eb28072b4f52d2
institution Directory Open Access Journal
issn 1970-5557
1970-5565
language English
last_indexed 2024-04-11T01:22:31Z
publishDate 2014-09-01
publisher Frontiers Media S.A.
record_format Article
series Oncology Reviews
spelling doaj.art-362c1bb02afa4d57a2eb28072b4f52d22023-01-03T10:59:32ZengFrontiers Media S.A.Oncology Reviews1970-55571970-55652014-09-018210.4081/oncol.2014.234200Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinomaKonstantinos Reveliotis0George Kalavrouziotis1Konstantinos Skevis2Andriani Charpidou3Rodoula Trigidou4Kostas Syrigos5Thoracic Department, General Hospital of Rhodes, RhodesDepartment of Cardiothoracic Surgery, Children’s Hospital Aghia Sophia, AthensThoracic Department, General Hospital of Rhodes, RhodesOncology Unit GPP, Sotiria General Hospital, Athens Medical SchoolOncology Unit GPP, Sotiria General Hospital, Athens Medical SchoolOncology Unit GPP, Sotiria General Hospital, Athens Medical SchoolThe use of sublobar resections as definitive management in stage I non-small cell lung carcinoma is a controversial topic in the medical community. We intend to report the latest developments and trends in relative indications for each of the above-mentioned surgical approaches for the treatment of stage I non-small cell lung carcinoma as well as the results of studies regarding local recurrence, disease-free survival and five-year survival rates. We reviewed 45 prospective and retrospective studies conducted over the last 25 years listed in the Pubmed and Scopus electronic databases. Trials were identified through bibliographies and a manual search in journals. Authors, citations, objectives and results were extracted. No meta-analysis was performed. Validation of results was discussed. Segmentectomies are superior to wedge resections in terms of local recurrences and cancer-related mortality rates. Sublobar resections are superior to lobectomy in preserving the pulmonary parenchyma. High-risk patients should undergo segmentectomy, whereas lobectomies are superior to segmentectomies only for tumors >2 cm (T2bN0M0) in terms of disease-free and overall 5-year survival. In most studies no significant differences were found in tumors <2 cm. Disease-free surgical margins are crucial to prevent local recurrences. Systematic lymphadenectomy is mandatory regardless of the type of resection used. In sublobar resections with less thorough nodal dissections, adjuvant radiotherapy can be used. This approach is preferable in case of prior resection. In pure bronchoalveolar carcinoma, segmentectomy is recommended. Sublobar resections are associated with a shorter hospital stay. The selection of the type of resection in T1aN0M0 tumors should depend on characteristic of the patient and the tumor. Patient age, cardiopulmonary reserve and tumor size are the most important factors to be considered. However further prospective randomized trials are needed to investigate the efficacy of minimal resections in early lung cancer patients.http://www.oncologyreviews.org/index.php/or/article/view/234the authors declare no conflict of interests.
spellingShingle Konstantinos Reveliotis
George Kalavrouziotis
Konstantinos Skevis
Andriani Charpidou
Rodoula Trigidou
Kostas Syrigos
Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
Oncology Reviews
the authors declare no conflict of interests.
title Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
title_full Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
title_fullStr Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
title_full_unstemmed Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
title_short Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
title_sort wedge resection and segmentectomy in patients with stage i non small cell lung carcinoma
topic the authors declare no conflict of interests.
url http://www.oncologyreviews.org/index.php/or/article/view/234
work_keys_str_mv AT konstantinosreveliotis wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma
AT georgekalavrouziotis wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma
AT konstantinosskevis wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma
AT andrianicharpidou wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma
AT rodoulatrigidou wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma
AT kostassyrigos wedgeresectionandsegmentectomyinpatientswithstageinonsmallcelllungcarcinoma